MedPath

SYMBICORT

These highlights do not include all the information needed to use SYMBICORT safely and effectively. See full prescribing information for SYMBICORT. SYMBICORT (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for oral inhalation use Initial U.S. Approval: 2006

Approved
Approval ID

6b78d08a-e098-4188-8f7f-94fbd5f396ef

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 21, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Budesonide and Formoterol Fumarate Dihydrate

PRODUCT DETAILS

NDC Product Code50090-1403
Application NumberNDA021929
Marketing CategoryC73594
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateOctober 17, 2023
Generic NameBudesonide and Formoterol Fumarate Dihydrate

INGREDIENTS (5)

FORMOTEROL FUMARATEActive
Quantity: 4.5 ug in 1 1
Code: W34SHF8J2K
Classification: ACTIB
BUDESONIDEActive
Quantity: 160 ug in 1 1
Code: Q3OKS62Q6X
Classification: ACTIB
APAFLURANEInactive
Code: R40P36GDK6
Classification: IACT
POLYETHYLENE GLYCOL 1000Inactive
Code: U076Q6Q621
Classification: IACT
POVIDONE K25Inactive
Code: K0KQV10C35
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SYMBICORT - FDA Drug Approval Details